20th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism

Dear Colleagues,

On behalf of the European Society of Endocrinology and the Russian Association of Endocrinology, we are delighted to invite you to Moscow for the 20th ESE Postgraduate Training Course in Endocrinology, Diabetes and Metabolism. The course will take place in the Radisson Blu Belorusskaya Hotel from 20 to 22 April 2017.

 Throughout the 20th ESE Postgraduate Training Course, participants are encouraged to actively participate in a variety of different sessions led by upcoming and world-renowned speakers. The programme covers all aspects of Endocrinology including diabetes, thyroid disease, neuroendocrinology, osteoporosis, calcium-phosphorous metabolism disturbance and many others.

There will be two sessions specifically for the presentation of recent research and clinical cases of interest. You are welcome to submit an abstract before the 19th of March 2017, if you wish to participate in the presentation. All accepted abstracts will be published in the official journal of the Russian Association of Endocrinology «Problems of Endocrinology», which is currently part of the SCOPUS database.

The course is designed for young endocrinologists and those in training, although endocrinologists of all ages and experience are welcome to attend. All attendees will receive European and Russian accreditation upon completion of the course.

We have a fixed number of places available on the Course, which will be assigned on a first come, first served basis, so please register as soon as possible. More details you can find on the Course website.

The official language of the course will be English.

With warm greetings,

 

Prof. Jens Bollerslev
ESE Education Committee Chair


Prof. Ivan Dedov
The President of the RAE

Prof. Galina Melnichenko
The Vice President of the RAE

Prof. Richard Feelders (Netherlands)

Dr. Zhanna Belaya (Russia)

Chairs of the local programme organizing committee

 

Website: http://esepostgraduate2017.com

Mohlo by vás zaujímať

SES listom z 18.5.2017 požiadala všetky zdravotné poisťovne zvážiť úhradu vyšetrení PSA a AMH

SES listom z 18.5.2017 požiadala všetky zdravotné poisťovne zvážiť úhradu vyšetrení PSA a AMH

čítať viac
Skupinové povolenia na terapeutické použitie neregistrovaných liekov Synacthen, GHRH, LHRH

Ministerstvo zdravotníctva SR zverejnilo Skupinové povolenia na terapeutické použitie neregistrovaných liekov Synacthen, GHRH, LHRH

čítať viac
Náhradou za AT10 Loesung sú Atiten kvapky 15 ml (dihydrotachysterol).

Ministerstvo Zdravotníctva SR schválilo použitie neregistrovaného lieku Atiten a všetky zdravotné poisťovne obdržali žiadosť o úhradu.

čítať viac